A detailed history of Israel Englander (Millennium Management LLC) transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 278,756 shares of VIGL stock, worth $454,372. This represents 0.0% of its overall portfolio holdings.

Number of Shares
278,756
Previous 334,807 16.74%
Holding current value
$454,372
Previous $1.34 Million 29.28%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.92 - $4.65 $163,668 - $260,637
-56,051 Reduced 16.74%
278,756 $947,000
Q2 2024

Aug 14, 2024

BUY
$2.51 - $4.66 $757,211 - $1.41 Million
301,678 Added 910.62%
334,807 $1.34 Million
Q1 2024

May 15, 2024

BUY
$2.68 - $3.63 $88,785 - $120,258
33,129 New
33,129 $112,000
Q1 2023

May 15, 2023

BUY
$8.77 - $12.7 $626,011 - $906,538
71,381 New
71,381 $699,000

Others Institutions Holding VIGL

About Vigil Neuroscience, Inc.


  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $46.1M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.